Structure Therapeutics (GPCR) News Today $27.09 -0.24 (-0.88%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$27.74 +0.66 (+2.42%) As of 05/2/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Structure Therapeutics Inc. (NASDAQ:GPCR) Shares Sold by RA Capital Management L.P.RA Capital Management L.P. cut its stake in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 20.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,517,418 shares of the company's stMay 3 at 7:49 AM | marketbeat.comStructure Therapeutics (GPCR) to Release Quarterly Earnings on ThursdayStructure Therapeutics (NASDAQ:GPCR) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-structure-therapeutics-inc-american-depositary-shares-stock/)May 3 at 6:05 AM | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Sets New 12-Month High - Should You Buy?Structure Therapeutics (NASDAQ:GPCR) Reaches New 1-Year High - Time to Buy?May 3 at 4:51 AM | marketbeat.comCitigroup Initiates Coverage of Structure Therapeutics Inc. - Depositary Receipt () (GPCR) with Buy RecommendationMay 3 at 2:56 AM | msn.comStructure draws new Buy at Citi on oral obesity drug pipelineMay 2 at 9:54 PM | msn.comMonashee Investment Management LLC Sells 27,608 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)Monashee Investment Management LLC trimmed its holdings in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 17.3% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 132,000 shares of the company's stock after selling 27,608 shares durinMay 2 at 7:48 AM | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Holdings Decreased by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD trimmed its position in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 33.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,394,306 shares of the company's stock after selMay 2 at 4:36 AM | marketbeat.com24,530 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Acquired by Mariner LLCMariner LLC bought a new position in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 24,530 shares of the company's stock, valued at approximately $665,000. Other hedgeMay 2 at 3:44 AM | marketbeat.comBarclays PLC Increases Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR)Barclays PLC boosted its position in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 42.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 115,671 shares of the company's stock after purchMay 2 at 3:43 AM | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Trading 5.2% Higher - Here's WhyStructure Therapeutics (NASDAQ:GPCR) Trading Up 5.2% - Should You Buy?May 1 at 1:17 PM | marketbeat.comFirst Light Asset Management LLC Trims Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR)First Light Asset Management LLC lowered its stake in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 21.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 398,855 shares of the company'April 30, 2025 | marketbeat.comForesite Capital Management VI LLC Acquires New Position in Structure Therapeutics Inc. (NASDAQ:GPCR)Foresite Capital Management VI LLC acquired a new stake in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 420,000 shares of the company's stock, valApril 30, 2025 | marketbeat.comBoothbay Fund Management LLC Has $2.26 Million Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR)Boothbay Fund Management LLC grew its stake in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 147.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 83,148 shares of the company's stock after buying an addiApril 30, 2025 | marketbeat.comViking among notable gainers as Pfizer raises deal prospectsApril 29, 2025 | msn.comIs Structure Therapeutics Inc. (NASDAQ:GPCR) the Most Promising Small-Cap Stock According to Analysts?April 26, 2025 | msn.comInvesco Ltd. Grows Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR)Invesco Ltd. lifted its holdings in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 4.1% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 371,767 shares of the company's stock after acquiring an additional 14,559 shares during theApril 25, 2025 | marketbeat.comStructure Therapeutics' (GPCR) Buy Rating Reaffirmed at HC WainwrightApril 25, 2025 | americanbankingnews.comH.C. Wainwright maintains buy on Structure Therapeutics sharesApril 24, 2025 | uk.investing.comStructure Therapeutics (NASDAQ:GPCR) Shares Down 3% - Here's What HappenedStructure Therapeutics (NASDAQ:GPCR) Stock Price Down 3% - Here's What HappenedApril 24, 2025 | marketbeat.comHC Wainwright Reiterates Buy Rating for Structure Therapeutics (NASDAQ:GPCR)HC Wainwright reaffirmed a "buy" rating and set a $80.00 price objective on shares of Structure Therapeutics in a report on Tuesday.April 24, 2025 | marketbeat.comSilverarc Capital Management LLC Has $4.13 Million Position in Structure Therapeutics Inc. (NASDAQ:GPCR)Silverarc Capital Management LLC grew its position in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 116.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 152,395 shares of the company's stock after purchasing an additionaApril 24, 2025 | marketbeat.comAnalysts Set Structure Therapeutics Inc. (NASDAQ:GPCR) Target Price at $81.29April 24, 2025 | americanbankingnews.comStructure Therapeutics (NASDAQ:GPCR) Stock Price Up 5.9% - Should You Buy?Structure Therapeutics (NASDAQ:GPCR) Trading 5.9% Higher - Still a Buy?April 23, 2025 | marketbeat.comRock Springs Capital Management LP Boosts Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR)Rock Springs Capital Management LP raised its holdings in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 1.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,080,963 shares of the compApril 23, 2025 | marketbeat.comCapital International Investors Purchases 103,059 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)Capital International Investors raised its position in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 6.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,619,081 shareApril 23, 2025 | marketbeat.comMarshall Wace LLP Grows Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR)Marshall Wace LLP increased its holdings in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 339.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 583,207 shares of the company's stock after buyApril 23, 2025 | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Given Consensus Recommendation of "Buy" by AnalystsShares of Structure Therapeutics Inc. (NASDAQ:GPCR - Get Free Report) have been given an average rating of "Buy" by the eight brokerages that are presently covering the firm, MarketBeat Ratings reports. Eight investment analysts have rated the stock with a buy rating. The average twelve-month pricApril 21, 2025 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Sees Large Volume Increase - Here's WhyStructure Therapeutics (NASDAQ:GPCR) Sees Large Volume Increase - What's Next?April 19, 2025 | marketbeat.comCapital Fund Management S.A. Has $1.82 Million Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR)Capital Fund Management S.A. increased its position in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 33.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 67,135 shares of the compApril 18, 2025 | marketbeat.comEli Lilly jumps as results from weight-loss pill study rival competitor’sApril 17, 2025 | markets.businessinsider.comWhy did Lilly data for oral GLP-1 boost Structure and Metsera?April 17, 2025 | seekingalpha.comSA Asks: What's the best weight-loss drug stock right now?April 17, 2025 | msn.comWhy did Lilly data for oral obesity drug boost Structure and Metsera?April 17, 2025 | msn.comStructure Therapeutics (NASDAQ:GPCR) Shares Gap Up - Here's WhyStructure Therapeutics (NASDAQ:GPCR) Shares Gap Up - Here's WhyApril 16, 2025 | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Position Cut by Alliancebernstein L.P.Alliancebernstein L.P. lowered its position in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 10.3% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 142,825 shares of the company's stock after selling 16,372 shares during the period. AllApril 16, 2025 | marketbeat.comWall Street Sees Pfizer's Weight-Loss Pill Exit As A Win For 2 Smaller Biotech Firms: Retail Turns BullishApril 15, 2025 | msn.comFmr LLC Sells 49,698 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)Fmr LLC lessened its holdings in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 0.8% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,078,746 shares of the company's stock after selling 49,698 sharesApril 15, 2025 | marketbeat.comJPMorgan says Pfizer news ‘mostly a positive’ for Structure, VikingApril 14, 2025 | markets.businessinsider.comSmaller obesity drugmakers jump after Pfizer scraps weight-loss pillApril 14, 2025 | markets.businessinsider.comStructure Therapeutics shares rise on Pfizer’s obesity drug exitApril 14, 2025 | in.investing.comWhat's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday?April 14, 2025 | benzinga.comStructure Therapeutics Inc. (NASDAQ:GPCR) Shares Purchased by Trexquant Investment LPTrexquant Investment LP boosted its stake in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 592.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 52,876 shares of the company's sApril 12, 2025 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Hits New 12-Month Low - Time to Sell?Structure Therapeutics (NASDAQ:GPCR) Hits New 1-Year Low - Here's WhyApril 11, 2025 | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Shares Sold by Federated Hermes Inc.Federated Hermes Inc. reduced its stake in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 15.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,045,958 shares of the company's stoApril 10, 2025 | marketbeat.com35,319 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Purchased by ADAR1 Capital Management LLCADAR1 Capital Management LLC bought a new position in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 35,319 shares of the company's stock, valued at approximately $95April 9, 2025 | marketbeat.comFranklin Resources Inc. Increases Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR)Franklin Resources Inc. boosted its position in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 4.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 738,090 shares of the company's stock afterApril 8, 2025 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Shares Up 7.5% - What's Next?Structure Therapeutics (NASDAQ:GPCR) Stock Price Up 7.5% - What's Next?April 6, 2025 | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Shares Sold by Cinctive Capital Management LPCinctive Capital Management LP decreased its holdings in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 71.8% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,065 shares of the company's stock afterApril 6, 2025 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Stock Price Up 7.5% - Here's WhyStructure Therapeutics (NASDAQ:GPCR) Stock Price Up 7.5% - Here's WhyApril 4, 2025 | marketbeat.comWellington Management Group LLP Has $211.15 Million Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR)Wellington Management Group LLP increased its position in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 0.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,785,614 shares of theApril 4, 2025 | marketbeat.com Get Structure Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GPCR and its competitors with MarketBeat's FREE daily newsletter. Email Address GPCR Media Mentions By Week GPCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GPCR News Sentiment▼0.960.58▲Average Medical News Sentiment GPCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GPCR Articles This Week▼155▲GPCR Articles Average Week Get Structure Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GPCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Axsome Therapeutics News Nuvalent News Verona Pharma News Grifols News Krystal Biotech News ADMA Biologics News Cytokinetics News Elanco Animal Health News Vaxcyte News Rhythm Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GPCR) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Structure Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Structure Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GPCR Stock Free GPCR Stock Alerts